S-OA-M Oral Abstracts - Session M - Lymphoma/Multiple Myeloma

Track: BMT Tandem "Scientific" Meeting
Sunday, February 17, 2013: 10:30 AM-12:00 PM
Ballroom A-D (Salt Palace Convention Center)
Chairs:
Brett Glotzbecker, MD and Ginna G Laport, MD
Summary:

Abstracts: #2539, 2552, 1995, 2711, 2350, 2609

80
Phase I/II Multicenter Clinical Trial of Lenalidomide Maintenance After Allogeneic Hematopoietic Cell Transplant (alloHCT) in Patients with High Risk (HR) Multiple Myeloma (MM)
Pamela S. Becker, Fred Hutchinson Cancer Research Center; Melissa Alsina, MD, Moffitt Cancer Center; Xiaobo Zhong, Medical College of Wisconsin; Parameswaran N. Hari, MD, MRCP, MS, Medical College of Wisconsin, Hematology/Oncology; Scott Rowley, MD, Hackensack University Medical Center; Edward A. Stadtmauer, MD, University of Pennsylvania; David Vesole, MD, PhD, Hackensack University Medical Center; Brent R. Logan, PhD, Medical College of Wisconsin; Daniel J. Weisdorf, MD, University of Minnesota; Muzaffar Qazilbash, MD, UT MD Anderson Cancer Center; Leslie Popplewell, MD, FACP, City of Hope National Medical Center; Willis H. Navarro, MD, University of California, San Francisco; Marcie Tomblyn, MD, MS, H. Lee Moffitt Cancer Center; Sergio A. Giralt, MD, Memorial Sloan-Kettering Cancer Center; Marcelo C. Pasquini, MD, MS, CIBMTR/Medical College of Wisconsin

81
Outcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid Irradiation and Anti-Thymocyte Globulin in Lymphoid Malignancies After Failed Autologous Transplantation
Abraham S Kanate, MD, Stanford University; Bradley Efron, PhD, Stanford University; Saurabh Chhabra, MD, Stanford University; Holbrook Kohrt, MD, Stanford University; Judith A. Shizuru, MD, PhD, Stanford University Medical Center; Ginna G Laport, MD, Stanford University Medical Center; David B. Miklos, MD, PhD, Stanford University Medical Center; Jonathan Benjamin, MD, PhD, Stanford University; Laura Johnston, MD, Stanford University; Sally Arai, MD, Stanford University; Wen-Kai Weng, MD, Stanford University; Robert Negrin, MD, Stanford University; Samuel Strober, MD, Stanford University Medical Center; Robert Lowsky, MD, Stanford University

82
Remission Duration ≤ 12 Months for Early Relapsed and Refractory Follicular Lymphoma Is Predictive of Early Failures Post-High Dose Therapy and Autologous Stem Cell Rescue
Matthew Alexander Lunning, D.O., Memorial Sloan-Kettering Cancer Center; Jocelyn Maragulia, MS, Memorial Sloan-Kettering Cancer Center; Craig H. Moskowitz, MD, Memorial Sloan-Kettering Cancer Center; Hugo Castro-Malaspina, M.D., Memorial Sloan-Kettering Cancer Center; Sergio A. Giralt, MD, Memorial Sloan-Kettering Cancer Center; Andrew D Zelenetz, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center; Craig Steven Sauter, MD, Memorial Sloan-Kettering Cancer Center

83
Autologous Transplantation As Consolidation Therapy for Primary and Secondary CNS Lymphoma- A Single Center Experience
Ramakrishnan Parameswaran, MD MRCP FRCPath, Avera Mckennan Hospital & University Health Center; Ahmed Galal, MD FRCPC, Avera Mckennan Hospital & University Health Center; Kelly McCaul, MD FRCPC, Avera Mckennan Hospital & University Health Center

84
Suppression of Involved Immunoglobulin Free Light Chain Post Therapy and Survival Outcomes Following Autologous Stem Cell Transplantation for Myeloma
Jacob Smeltzer, Mayo Clinic; Morie Gertz, MD, Mayo Clinic; S. Vincent Rajkumar, Mayo Clinic; Angeal Dispenzieri, Mayo Clinic; Martha Lacy, MD, Mayo Clinic; Francis Buadi, MD, Mayo Clinic; Suzanne Hayman, MD, Mayo Clinic; David Dingli, Mayo Clinic; Prashant Kapoor, Mayo Clinic; Shaji Kumar, MD, Mayo Clinic

85
CT7/MAGE-C1 Expression and Immune Responses Following Allogeneic Transplant for Multiple Myeloma
Eleanor M. Tyler, Sloan-Kettering Institute; Achim A. Jungbluth, MD, Ludwig Institute for Cancer Research, New York Branch; Sacha Gnjatic, PhD, Ludwig Institute for Cancer Research, New York Branch; Richard O'Reilly, MD, Memorial Sloan-Kettering Cancer Center; Guenther Koehne, MD, PhD, Memorial Sloan-Kettering Cancer Center